1. Home
  2. BOX vs INDV Comparison

BOX vs INDV Comparison

Compare BOX & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Box Inc.

BOX

Box Inc.

HOLD

Current Price

$23.95

Market Cap

3.4B

Sector

Technology

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$32.56

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOX
INDV
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.7B
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
BOX
INDV
Price
$23.95
$32.56
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$35.57
N/A
AVG Volume (30 Days)
2.3M
1.8M
Earning Date
05-26-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8100.00
EPS
0.58
1.64
Revenue
$506,142,000.00
$1,239,000,000.00
Revenue This Year
$9.41
N/A
Revenue Next Year
$8.15
N/A
P/E Ratio
$40.92
$19.95
Revenue Growth
26.98
4.29
52 Week Low
$21.34
$8.69
52 Week High
$38.80
$38.00

Technical Indicators

Market Signals
Indicator
BOX
INDV
Relative Strength Index (RSI) 52.36 54.69
Support Level $23.29 $31.70
Resistance Level $24.55 $35.75
Average True Range (ATR) 0.88 1.25
MACD 0.12 0.30
Stochastic Oscillator 80.84 74.01

Price Performance

Historical Comparison
BOX
INDV

About BOX Box Inc.

Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: